{
    "organizations": [],
    "uuid": "52ace4217f4c8347505e2ce6ea3de2aa9eeb02dc",
    "author": "",
    "url": "https://www.reuters.com/article/brief-telix-pharmaceuticals-establishes/brief-telix-pharmaceuticals-establishes-japanese-subsidiary-idUSFWN1P900R",
    "ord_in_thread": 0,
    "title": "BRIEF-‍Telix Pharmaceuticals establishes Japanese subsidiary",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 14 (Reuters) - Telix Pharmaceuticals Ltd:\n* ‍TELIX PHARMACEUTICALS ESTABLISHES JAPANESE SUBSIDIARY, APPOINTS KEY EXECUTIVES​\n* ‍ANNOUNCED ESTABLISHMENT TELIX PHARMACEUTICALS (JAPAN) LTD (“TELIX JAPAN”)​\n* TELIX PHARMACEUTICALS- ‍TO LEAD TELIX JAPAN, SHINTARO NISHIMURA & TAKESHI OKA APPOINTED AS PRESIDENT & COO, AND CHIEF MEDICAL OFFICER (JAPAN), RESPECTIVELY​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-15T04:23:00.000+02:00",
    "crawled": "2018-01-15T04:40:01.040+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "telix",
        "pharmaceutical",
        "ltd",
        "pharmaceutical",
        "establishes",
        "japanese",
        "subsidiary",
        "appoints",
        "key",
        "establishment",
        "telix",
        "pharmaceutical",
        "japan",
        "ltd",
        "telix",
        "japan",
        "telix",
        "lead",
        "telix",
        "japan",
        "shintaro",
        "nishimura",
        "takeshi",
        "oka",
        "appointed",
        "president",
        "coo",
        "chief",
        "medical",
        "officer",
        "japan",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}